| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A boost for poor graft function
|
Mohty, Mohamad
|
|
|
8 |
17 |
p. 4727-4728
|
artikel
|
| 2 |
A budget impact analysis of gene therapy for sickle cell disease: an updated analysis
|
DeMartino, Patrick C.
|
|
|
8 |
17 |
p. 4658-4661
|
artikel
|
| 3 |
Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis
|
Wang, Michael
|
|
|
8 |
17 |
p. 4539-4548
|
artikel
|
| 4 |
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survival
|
Shapiro, Roman M.
|
|
|
8 |
17 |
p. 4729-4737
|
artikel
|
| 5 |
Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia
|
Palmer, Andrew
|
|
|
8 |
17 |
p. 4647-4650
|
artikel
|
| 6 |
Blood biodistribution and vector shedding of valoctocogene roxaparvovec in people with severe hemophilia A
|
Agarwal, Suresh
|
|
|
8 |
17 |
p. 4606-4615
|
artikel
|
| 7 |
Caplacizumab in pediatric immune thrombotic thrombocytopenic purpura: the UK TTP Registry experience
|
Taylor, Alice
|
|
|
8 |
17 |
p. 4563-4567
|
artikel
|
| 8 |
Clinical outcomes after idecabtagene vicleucel in older patients with multiple myeloma: a multicenter real-world experience
|
Kalariya, Nilesh M.
|
|
|
8 |
17 |
p. 4679-4688
|
artikel
|
| 9 |
CMV reactivation during pretransplantation evaluation: a novel risk factor for posttransplantation CMV reactivation
|
Zamora, Danniel
|
|
|
8 |
17 |
p. 4568-4580
|
artikel
|
| 10 |
Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation
|
Pidala, Joseph A.
|
|
|
8 |
17 |
p. 4651-4657
|
artikel
|
| 11 |
Conditioning with anti-CD47 and anti-CD117 plus JAK inhibition enables toxic payload-free allogeneic transplantation
|
Persaud, Stephen P.
|
|
|
8 |
17 |
p. 4502-4506
|
artikel
|
| 12 |
COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network Study
|
Anderson, Alan R.
|
|
|
8 |
17 |
p. 4549-4553
|
artikel
|
| 13 |
Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients
|
Boothby, Aaron B.
|
|
|
8 |
17 |
p. 4689-4699
|
artikel
|
| 14 |
Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients
|
Dadwal, Sanjeet S.
|
|
|
8 |
17 |
p. 4740-4750
|
artikel
|
| 15 |
Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AML
|
Grenier, Julien M. P.
|
|
|
8 |
17 |
p. 4662-4678
|
artikel
|
| 16 |
Health care utilization and costs for frail vs nonfrail patients with diffuse large B-cell lymphoma
|
Vijenthira, Abi
|
|
|
8 |
17 |
p. 4625-4632
|
artikel
|
| 17 |
Immune modulation permits tolerance and engraftment in a murine model of late-gestation transplantation
|
Riley, John S.
|
|
|
8 |
17 |
p. 4523-4538
|
artikel
|
| 18 |
Impact of patient demographics on treatment outcomes in AML: a population-based registry in England, 2013-2020
|
Liu, Hanhua
|
|
|
8 |
17 |
p. 4593-4605
|
artikel
|
| 19 |
In utero hematopoietic stem cell transplantation for Fanconi anemia
|
Swartzrock, Leah
|
|
|
8 |
17 |
p. 4554-4558
|
artikel
|
| 20 |
Joseph JM, Hillengass J, Tang L, et al. Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population. Blood Adv. 2024;8(3):538-548.
|
|
|
|
8 |
17 |
p. 4507-4510
|
artikel
|
| 21 |
Myo1c drives actin-dependent VWF expulsion from EC WPBs
|
Rusu, Luiza
|
|
|
8 |
17 |
p. 4711-4713
|
artikel
|
| 22 |
Myosin-1C augments endothelial secretion of von Willebrand factor by linking contractile actomyosin machinery to the plasma membrane
|
El-Mansi, Sammy
|
|
|
8 |
17 |
p. 4714-4726
|
artikel
|
| 23 |
Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma
|
Witzig, Thomas
|
|
|
8 |
17 |
p. 4581-4592
|
artikel
|
| 24 |
Prophylactic VSTs: a promising start but still work to do
|
Elgarten, Caitlin W.
|
|
|
8 |
17 |
p. 4738-4739
|
artikel
|
| 25 |
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis
|
Gerds, Aaron T.
|
|
|
8 |
17 |
p. 4511-4522
|
artikel
|
| 26 |
T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells
|
van Bruggen, Jaco A. C.
|
|
|
8 |
17 |
p. 4633-4646
|
artikel
|
| 27 |
The American Society of Hematology Health Equity Compendium: examining health equity across the Blood journals
|
Fingrut, Warren B.
|
|
|
8 |
17 |
p. 4616-4624
|
artikel
|
| 28 |
The rules of T-cell engagement: current state of CAR T cells and bispecific antibodies in B-cell lymphomas
|
Haydu, J. Erika
|
|
|
8 |
17 |
p. 4700-4710
|
artikel
|
| 29 |
Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinib
|
Aslan, Burcu
|
|
|
8 |
17 |
p. 4487-4501
|
artikel
|
| 30 |
Transformation of marginal zone lymphoma to Hodgkin lymphoma
|
Moalem, Kamilia N.
|
|
|
8 |
17 |
p. 4559-4562
|
artikel
|
Tijdschrift beschrijving